STAT News

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.

作者 STAT News

1 分钟阅读
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察